Eli Lilly & Co. (LLY) Tops Q1 EPS Views; Maintains Outlook
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,183.46 +0.13%
Revenue Growth %: +26.6%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +26.6%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.24, $0.08 better than the analyst estimate of $1.16. Revenue for the quarter came in at $5.84 million versus the consensus estimate of $5.7 billion.
Maintains outlook.
Maintains outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
